University of Oxford is currently studying ivermectin as a possible therapy against COVID-19 in the UK

UK – Researchers from the university of Oxford under the PRINCIPLE study project are currently giving Ivermectin, a widely used anti-parasitic drug, to over-50s with COVID symptoms to see if it can keep them out of hospital. PRINCIPLE is a nationwide clinical study from the University of Oxford in collaboration with the British government trying to find COVID-19 treatments for recovery at home. The project is currently having any willing citizen over-50s with an underlying health condition or experiencing breathlessness and have had COVID symptoms for up to 14 days…

Read More

Cuba inches closer to rolling out its vaccines soberana and Abdala

CUBA – The Caribbean island nation of 11 million people, which has been under a strict United States (US) trade embargo for decades, is in process of developing five experimental shots, including Soberana 02 and Abdala, which reached final-stage trials last month. With both Soberana and Abdala in stage-three clinical trials, Cuba is racing towards potentially becoming the first country in Latin America to develop its own shot against the coronavirus. The names of the vaccines reveal much about how Cuba sees its national effort, Soberana translates as “sovereign”, while…

Read More

Pfizer’s tofacitinib gains usage traction based on data from Brazilian hospitalized patients

USA – Pfizer Inc. and The Academic Research Organization (ARO) from the Hospital Israelita Albert Einstein announced that the findings from the STOP-COVID study came out positive. The New England Journal of Medicine published positive findings from the study evaluating the efficacy and safety of oral Janus kinase (JAK) inhibitor tofacitinib in 289 hospitalized adult patients with COVID-19 pneumonia who were not on ventilation. Tofacitinib is a type of drug known as a Janus kinase (JAK) inhibitor that works by blocking the action of Janus kinase enzymes, which are involved…

Read More

Sun Pharma announces settlement of patent litigation with Celgene in US

USA – Sun Pharmaceutical Industries today announced settlement of patent litigation for generic Revlimid (lenalidomide) in the US. Lenalidomide, sold under the trade name Revlimid among others, is a medication used to treat multiple myeloma (MM) and myelodysplastic syndromes (MDS), cancer forms that fall under leukemia. Multiple myeloma is a relatively uncommon cancer. In the United States, the lifetime risk of getting multiple myeloma is 1 in 132 (0.76%). The American Cancer Society’s estimates for multiple myeloma in the United States for 2021 are, About 34,920 new cases will be…

Read More

Boehringer Ingelheim’s Pradaxa approved by the FDA for oral pediatric use

USA – The Food and Drug Administration (FDA) has approved Boehringer Ingelheim’s Pradaxa as the first oral blood thinning medication suitable for children 12 years and below in the USA. The medication Pradaxa will be available for use for children with venous thromboembolism immediately after treatment with a blood thinner given by injection for at least five days. Venous thromboembolism (VTE) is a disorder that includes deep vein thrombosis and pulmonary embolism with deep vein thrombosis (DVT) occurring when a blood clot forms in a deep vein, usually in the…

Read More

The global mobile health and fitness sensor market expected to grow to $7.7 billion

USA – The global mobile health and fitness sensor market is expected to reach an estimated $7.7 billion by 2026, according to Reportlinker, a tech company that uses artificial intelligence to deliver market data and forecasts and thus help research, business development or marketing strategy. Mobile health (mHealth) is the monitoring and sharing of health information via mobile technology such as wearables and health tracking apps. The use of mobile devices and wireless technology to monitor symptoms and deliver care allows physicians to make diagnoses quicker and with fewer errors.…

Read More

G7 summit outlines health pact to stop future pandemics

ENGLAND – G7 leaders are on Saturday set to agree a joint declaration aimed at preventing another pandemic, as they resume wide-ranging talks at their first in-person summit in almost two years. The group of leading economies — Britain, Canada, France, Germany, Italy, Japan and the United States — will also try to showcase Western democratic cohesion against a resurgent China and recalcitrant Russia. They will be joined by the leaders of Australia, South Africa and South Korea, along with India taking part remotely, as the agenda broadens to foreign…

Read More

FDA grants approval for ADUHELM as the first and only Alzheimer’s disease treatment

USA – U.S. Food and Drug Administration has approved Biogens’ Aduhelm (aducanumab) for the treatment of Alzheimer’s, a debilitating disease affecting 6.2 million Americans, the first new treatment approved for Alzheimer’s since 2003. Aduhelm has been approved using the accelerated approval pathway, which can be used for a drug for a serious or life-threatening illness that provides a meaningful therapeutic advantage over existing treatments. Currently available therapies only treat symptoms of the disease whereas this treatment option is the first therapy to target and affect the underlying disease process of…

Read More

Dr Reddy’s recalls 2,980 bottles of cholesterol lowering drug in US

INDIA – Drug major Dr Reddy’s Laboratories is recalling 2,980 bottles of Atorvastatin Calcium tablets in the US due to quality issues. Atorvastatin is indicated to lower cholesterol in the blood for adults and children over ten years of age. The drug is also prescribed to lower the risk of heart attack and stroke in patients with cardiovascular diseases, diabetes, and other risk factors such as eye problems, kidney diseases, or high blood pressure. As per the US Food and Drug Administration’s latest Enforcement report, the Hyderabad-based drug major is…

Read More

Moderna says its COVID vaccine is safe and effective in adolescents aged 12 to 17

U.S – Leading pharmaceutical manufacturer Moderna says that clinical trials have proved its COVID shot 100 percent effective and safe for use among teenagers. The company seeks to acquire FDA approval before summer to administer the vaccine. It would be the second Covid-19 vaccine available for the age group if it is authorized for use, in addition to the Pfizer BioNTech vaccine. Moderna CEO Stephane Bancel said that the firm is glad the mRNA-1273 was highly effective at preventing covid amongst adolescents, “we remain committed to doing our part to help…

Read More